PUBLISHER: The Business Research Company | PRODUCT CODE: 1945454
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945454
Lancing devices and equipment are medical tools designed to obtain small blood samples, typically for glucose testing in diabetic patients. These devices consist of a lancet, a small needle or blade, and a mechanism that punctures the skin, usually on the fingertip, to draw blood. Lancing devices often feature adjustable depth settings to control the penetration and minimize discomfort. They are essential for routine blood glucose monitoring and other diagnostic tests that require capillary blood samples.
The primary products in the category of lancing devices and equipment include safety lancets and standard lancets. Safety lancets are sterile, single-use devices designed for the collection of capillary blood samples. These lancing devices and equipment come in both reusable and disposable variations and are available in various penetration depths, including 0.8mm-1mm, 1.1mm-1.5mm, 1.6mm-2.0mm, and others. The end-users for these devices encompass hospitals and clinics, homecare and home diagnostics, diagnostic centers and medical institutions, research and academic laboratories, as well as various other healthcare settings.
Tariffs are influencing the lancing devices and equipment market by increasing costs of imported stainless steel needles, plastics, sterilization materials, and automated assembly equipment. Manufacturers and healthcare providers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on mass-produced disposable devices. These tariffs are raising unit costs and affecting pricing strategies. However, they are also encouraging regional manufacturing, localized sourcing of components, and increased investment in automated, high-volume production facilities.
The lancing devices and equipment market research report is one of a series of new reports from The Business Research Company that provides lancing devices and equipment market statistics, including lancing devices and equipment industry global market size, regional shares, competitors with a lancing devices and equipment market share, detailed lancing devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the lancing devices and equipment industry. This lancing devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The lancing devices and equipment market size has grown strongly in recent years. It will grow from $3.25 billion in 2025 to $3.52 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising prevalence of diabetes, expansion of self-monitoring blood glucose practices, increased availability of disposable medical devices, improvements in lancet safety designs, growth of point-of-care diagnostics.
The lancing devices and equipment market size is expected to see strong growth in the next few years. It will grow to $4.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for home diagnostics solutions, rising focus on patient comfort and compliance, expansion of chronic disease monitoring programs, growing adoption of minimally invasive sampling devices, increasing investments in personal healthcare technologies. Major trends in the forecast period include increasing adoption of single-use safety lancets, rising demand for pain-minimized sampling devices, growing use of home-based glucose monitoring, expansion of adjustable depth lancing technologies, enhanced focus on infection control.
The rising prevalence of diabetes is expected to drive the growth of the lancing devices and equipment market. Diabetes is a chronic metabolic disorder marked by elevated blood glucose levels, necessitating regular monitoring to effectively manage the condition and prevent complications such as neuropathy, cardiovascular disease, and kidney damage. The increase in diabetes cases is largely attributed to rising obesity rates, which contribute to insulin resistance and metabolic dysfunction, leading to the development of the disease. This growing prevalence boosts the demand for lancing devices and equipment, as people need safe, accurate, and user-friendly blood sampling tools for frequent glucose testing, either at home or in clinical settings. For example, in February 2025, The Guardian, a UK-based news organization, reported that a total of 12.2 million people in the United Kingdom were affected by diabetes or non-diabetic hyperglycemia, including 4.6 million diagnosed with diabetes, 1.3 million with undiagnosed diabetes, and 6.3 million with non-diabetic hyperglycemia. This represents an increase from the 12.1 million cases in 2023-2024. As a result, the rising prevalence of diabetes is fueling the growth of the lancing devices and equipment market.
Major companies operating in the lancing devices and equipment market are developing innovative products such as disposable lancing devices to offer a more convenient and comfortable blood sugar monitoring experience. Disposable lancing devices are small, portable devices that puncture the skin and collect a small blood sample for glucose testing. For example, in August 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced Accu-Chek Pico, a fully disposable lancing device designed to simplify and enhance blood sugar monitoring, particularly for older adults with diabetes. It offers multiple benefits, including ease of use, gentleness on the skin, consistent lancing depths, and full disposability. It is also compatible with various Accu-Chek blood glucose meters, ensuring ease of use for individuals with diabetes.
In October 2023, Novo Nordisk acquired Biocorp for $164.5 million. This acquisition is aimed at strengthening Novo Nordisk's investments in drug delivery systems and medical devices, aligning with their focus on diabetes care solutions. The acquisition enhances Novo Nordisk's position in the diabetes market and boosts its capabilities in developing advanced lancing devices and drug delivery systems through innovative technology integration. Biocorp, a France-based company, specializes in developing blood glucose meters, lancing devices, and insulin pumps.
Major companies operating in the lancing devices and equipment market are Abbott laboratories, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche AG, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Becton Dickinson and Company, Bayer AG, Medtronic plc, ARKRAY Inc., Sanofi S.A., Ypsomed Holding AG, Sarstedt AG & Co., Greiner Bio-One, HTL-STREFA S.A, Guangzhou Improve Medical Instruments Co. Ltd., UltiMed Inc., Allison Medical Inc., Artsana S.p.a., Perrigo Diabetes Care, MedExel Co. Ltd., Simple Diagnostics, Stat Medical Inc., Trividia Health, Eli Lilly and Company, Roche Diagnostics, Terumo Corporation, LifeScan, Dynarex Corporation, Dealmed Medical Supplies LLC, Advanced Diabetic Solutions, Medline Industries Inc., Owen Mumford, ARKRAY USA Inc., Nipro Diagnostics Inc., AgaMatrix Inc., Nova Biomedical, Prodigy Diabetes Care LLC, ACON Laboratories Inc.
North America was the largest region in the global lancing devices and equipment market in 2025. Western Europe was the second-largest region in the lancing devices and equipment market. The regions covered in the lancing devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the lancing devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The lancing devices and equipment market consist of sales of safety lancets and standard lancets, flake lancets And fixed depth lancet. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lancing Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses lancing devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for lancing devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lancing devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.